Oragenics (OGEN) Payables (2010 - 2026)
Oragenics' (OGEN) quarterly Payables came in at $1.3 million in Q1 2026, down 68.69% YoY from $4.2 million in Q1 2025, and down 28.43% on a QoQ basis from $1.8 million in Q4 2025.
Oragenics (OGEN) Payables (2010 - 2026) Analysis & Trends
Oragenics (OGEN) has 17 years of Payables data on file, last reported at $1.3 million in Q1 2026.
- Quarterly Payables fell 68.69% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 68.69% YoY) and the FY2025 annual result came in at $1.8 million, up 8.49% from the prior year.
- Payables slipped to $1.3 million in Q1 2026, from $1.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $4.3 million in Q2 2025 to a low of $514330.0 in Q4 2022.
- A 5-year average of $1.8 million and a median of $1.4 million in 2023 frame the typical range for Payables.
- Annual changes were most pronounced in 2025 — Payables surged 407.77% — and 2026, when it slumped 68.69%.
- Tracing OGEN's Payables over 5 years: stood at $514330.0 in 2022, then surged by 247.71% to $1.8 million in 2023, then slipped by 5.81% to $1.7 million in 2024, then increased by 8.49% to $1.8 million in 2025, then retreated by 28.43% to $1.3 million in 2026.
- The last three Payables figures came in at $1.3 million (Q1 2026), $1.8 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 108.02 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 428.93 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 35.57 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 622.65 Mn |
| 10 | Oragenics | 2.38 Mn | 2.38 Mn | - | 1.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.83 Mn |
| Sep 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | 1.68 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.38 Mn |
| Mar 31, 2024 | 822,631.00 |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 951,019.00 |
| Mar 31, 2023 | 1.05 Mn |
| Dec 31, 2022 | 514,330.00 |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 321,356.00 |
| Sep 30, 2021 | 2.01 Mn |